Pluri Inc. cotiza a 0.97 USD y tiene una capitalización bursátil de $12M. En los últimos 12 meses ha facturado $1M con un margen de flujo de caja libre del -1990.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic c…
| Periodo | 2025-11 | 2025-09 | 2023-02 | 2022-11 |
|---|---|---|---|---|
| Real | $-0.65 | $-1.00 | $-1.92 | $-1.52 |
| Estimado | $-0.74 | $-0.73 | $-2.56 | $-2.56 |
| Sorpresa | +12.2% | -37.0% | +25.0% | +40.6% |
| Métrica | PLUR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 44.6% | 57.0% | -12.4% |
| Operating Margin | -2454.5% | -38.6% | -2415.9% |
| Net Margin | -2344.6% | -33.6% | -2311.0% |
| FCF Margin | -1990.3% | -13.9% | -1976.4% |
| ROE | — | -40.4% | — |
| ROA | -95.8% | -32.0% | -63.7% |
| Current Ratio | 0.27 | 2.84 | -2.57 |
| Debt / Equity | — | 0.28 | — |